AzTrials
AzTrials

Neurological DisorderSPS-AFONCT03146598

Side Pole Static Ankle Foot Orthosis in Children With Neurological Disorders

An observational study of Neurological Disorder, run by BERTHILLIER Julien.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Transverse-plane foot deformities are a frequently encountered issue in children with neurological disorders. They are the source of many symptoms, such as pain and walking difficulties, making their prevention very important. Read more about this study

Who is it for?
Ages 1 year to 16 years
Conditions the study is for
Neurological Disorder
How many people
100 participants
Where
No sites listed yet
Study dates
1 Jan 2012to 1 Jan 2012
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Patient from the department of physical medicine and pediatric rehabilitation L'Escale (Lyon, France)

Who may be able to join

  • regularly follow-up in the department of physical medicine and pediatric rehabilitation L'Escale (Lyon, France)
  • presenting at least unilateral transverse-plane foot deformity within the context of a neurological disorder
  • having a first prescription of SPS AFO between December 2001 and December 2011.

Who cannot join

  • None

About this study

Official title: Use and Tolerability of a Side Pole Static Ankle Foot Orthosis in Children With Neurological Disorders

Transverse-plane foot deformities are a frequently encountered issue in children with neurological disorders. They are the source of many symptoms, such as pain and walking difficulties, making their prevention very important. It is thus important to prevent the occurrence of transverse-plane foot deformities and limit their development regarding the high risk of morbidity. In order to prevent such deformities, in the department of pediatric physical medicine and rehabilitation department of Lyon, since 2001 the investigator use a side pole static ankle foot orthosis (SPS AFO) in children with a neurological disorder predisposing such deformities. The aim of the study this study is to describe the use, tolerability and potential side effects of this orthosis in children with neurological disorders from the investigator's department

Being tested
No intervention as it is a observational study
Keywords
Foot deformity, Orthopaedic management, prevention, side pole static ankle foot orthosis
Medical subject headings
Nervous System Diseases, Foot Deformities

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No intervention as it is a observational studyOther

    No intervention as it is a observational study

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Duration of the SPS AFO wearing

    Duration of the SPS AFO wearing

    Measured: At 3 months after SPS AFO implementation

Secondary outcomes (7)
  1. Frequency of the SPS AFO wearing

    Frequency of the SPS AFO wearing

    Measured: At 3 months after SPS AFO implementation

  2. Duration of the SPS AFO wearing

    Duration of the SPS AFO wearing

    Measured: At 1 year after SPS AFO implementation

  3. Frequency of the SPS AFO wearing

    Frequency of the SPS AFO wearing

    Measured: At 1 year after SPS AFO implementation

  4. Duration of the SPS AFO wearing

    Duration of the SPS AFO wearing

    Measured: at 2 year after SPS AFO implementation

  5. Frequency of the SPS AFO wearing

    Frequency of the SPS AFO wearing

    Measured: at 2 year after SPS AFO implementation

  6. Duration of the SPS AFO wearing

    Duration of the SPS AFO wearing

    Measured: At 4 years after SPS AFO implementation

  7. Frequency of the SPS AFO wearing

    Frequency of the SPS AFO wearing

    Measured: At 4 years after SPS AFO implementation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 May 2017
  2. Study start1 Jan 2012
  3. Primary completion1 Jan 2012
  4. Study completion1 Jan 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03146598
Sponsor's protocol ID
2015-68
Acronym
SPS-AFO
Status last verified
May 2017
First submitted
2 May 2017
Last updated
10 May 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Neurological Disorder, run by BERTHILLIER Julien.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 May 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Duration of the SPS AFO wearing (time frame: At 3 months after SPS AFO implementation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 May 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in